Skip to main content

Capital Research Global Investors

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1422848 Los Angeles, CA

Position in TAK

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$309,341,810
-$44,468,325 QoQ
Shares Held
19,297,680
+1.0% QoQ
Ownership
0.604%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1
of 376 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TAK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Capital Research Global Investors holds $379,822,888 across 2 Drug Manufacturers - Specialty & Generic names. TAK ranks #1 (81.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TAK
Takeda Pharmaceutical Co Ltd
This page
19,297,680 $309,341,810

All Filings in TAK

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $309,341,810 19,297,680
2026-03-31 $353,810,135 19,104,219
2025-12-31 $210,258,775 13,486,772
2025-09-30 $196,236,448 13,404,129
2025-06-30 $205,549,558 13,295,573
2025-03-31 $196,298,929 13,201,004
2024-12-31 $174,271,672 13,162,513
2024-09-30 $186,811,040 13,137,204
2024-06-30 $169,858,307 13,126,608
2024-03-31 $182,263,607 13,121,930
2023-12-31 $204,029,677 14,297,805
2023-09-30 $213,398,733 13,794,359
2023-06-30 $216,606,982 13,787,841
2023-03-31 $223,789,500 13,579,460
2022-12-31 $41,747,737 2,676,137
2020-12-31 $1,190,826 65,430
2020-09-30 $987,890 55,375
2020-06-30 $920,400 51,333
2020-03-31 $541,333 35,661